ArticleBone marrow transplantation2012
Growth factor plus preemptive ('just-in-time') plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure.
L J Costa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it